Marijuana Stocks, Federal Reform And The Future Of Legal Cannabis
Cannabis stocks are entering a potentially transformative period as federal reform takes hold. Stronger business fundamentals and wider market access are reshaping the legal cannabis industry. For cannabis investors and enthusiasts, this moment represents more than short-term stock-market excitement—it reflects the gradual evolution of cannabis from a restricted market into a more established American industry.
The federal rescheduling of state-licensed medical marijuana to Schedule III is an important catalyst. It may reduce certain Section 280E tax burdens, encourage medical research, and improve operating conditions for qualifying cannabis businesses. However, rescheduling does not create nationwide legalization, and many regulatory barriers remain.
Investor access is also improving. Trulieve became the first U.S. cannabis operator listed on the New York Stock Exchange, creating greater visibility for marijuana stocks and potentially establishing a path for other operators. Meanwhile, companies such as Green Thumb Industries and Cresco Labs have reported positive net income, revenue growth, or operating cash flow—evidence that leading businesses are becoming more financially disciplined.
For enthusiasts, continued product innovation, expanding medical access, and growing consumer acceptance strengthen the industry’s long-term cultural relevance. For investors, the key is separating genuine progress from temporary hype.
The top marijuana stocks will likely be companies that protect margins, generate cash, manage debt, and build trusted brands. Pot stocks remain volatile, but today’s cannabis industry offers investors more measurable fundamentals—and more credible long-term catalysts—than it did during earlier speculative cycles. Below are several marijuana stocks to watch now.
Top Marijuana Stock Picks For 2026
- Jushi Holdings Inc. (OTC:JUSHF)
- Trulieve Cannabis Corp. (NYSE:TRLV)
- Curaleaf Holdings, Inc. (OTC:CURLF)
Jushi Holdings Inc.
Among smaller cannabis stocks, Jushi Holdings is a vertically integrated multistate operator involved in cultivation, manufacturing, wholesale distribution, and retail. Its dispensaries primarily operate under the Beyond Hello brand, while its product portfolio includes flower, concentrates, vapes, pre-rolls and edibles. At the end of the second quarter, Jushi operated 42 dispensaries across eight states. Jushi reported encouraging growth in Q2 2026. 
Revenue increased 10% year over year to $71.3 million, led by retail growth in Ohio and Virginia. Wholesale revenue climbed 68% to a quarterly record of $9.4 million, while adjusted EBITDA reached $13.3 million. Its net loss improved from $12.3 million to $7.3 million. Virginia represents an important future catalyst: Jushi already operates six dispensaries there, and regulated adult-use sales are scheduled to begin July 1, 2027.
The primary investor concern is its balance sheet. Jushi held $35.5 million in cash against approximately $219.8 million of debt subject to scheduled repayments, while quarterly operating cash flow was only $0.8 million. For investors, JUSHF offers meaningful growth potential, but financing costs, dilution risk, and execution in Virginia deserve close attention.
Trulieve Cannabis Corp.
Trulieve is one of the largest vertically integrated marijuana companies in the United States. The company cultivates, manufactures, and sells branded cannabis products through 207 dispensaries, with particularly strong medical-market positions in Florida, Georgia, Pennsylvania, and West Virginia. In 2026, Trulieve became the first U.S. plant-touching cannabis operator listed on the New York Stock Exchange.
Second-quarter revenue was $271 million, down 10% year over year, but Trulieve maintained a strong 60% gross margin. The company generated $53 million in operating cash flow and $32 million in free cash flow during the quarter, finishing with $325 million in cash. Adjusted net income was $20 million and adjusted EBITDA reached $98 million. The reported $406 million GAAP loss requires context: approximately $407 million resulted from the Harvest deconsolidation and related investment accounting.
Still, declining revenue and lower adjusted EBITDA show that operational pressures cannot be ignored. Trulieve’s NYSE listing, cash generation, Georgia pharmacy distribution and $50 million share-repurchase authorization strengthen its investor profile. The major risks include dependence on core markets, regulatory uncertainty and the challenge of returning to sustainable revenue growth. Among marijuana stocks, TRLV stands out for scale, liquidity and cash flow—but execution remains essential.
[Read More] 3 High-Dividend Marijuana Stocks to Watch in September 2026
Curaleaf Holdings, Inc.
Curaleaf Holdings is a major international cannabis company with cultivation, manufacturing, wholesale and retail operations across the United States and Europe. Its portfolio includes Curaleaf, Select, Grassroots, Find and JAMS, giving the business exposure to flower, vapes, edibles, concentrates and medical cannabis. CURLF trades on the OTCQX market, while its Canadian-listed shares trade as CURA.
Curaleaf reported Q2 2026 revenue of $340.1 million, increasing 10% year over year. Gross margin improved to 50%, and the company recorded $12.5 million in income from continuing operations compared with a $48.1 million loss one year earlier. International revenue grew 26% to $51.4 million, supported by expanding medical-cannabis sales in Germany and the United Kingdom.
The company’s most notable recent development is its unsolicited approximately $272 million takeover offer for Aurora Cannabis. Aurora’s board rejected the proposal as inadequate, creating uncertainty around the transaction and its potential financing, dilution, and integration demands.
[Read More] Cannabis Stocks In 2026: Improving Fundamentals Meet A Changing Market
For investors, Curaleaf offers broad geographic reach and growing international exposure. However, debt, acquisition risk, federal restrictions and competitive pricing remain important concerns. CURLF may benefit from industry consolidation, but investors should watch profitability, leverage, and the outcome of the Aurora bid.
MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
